Companies: 10,795·Total market cap: $144.5T
PolyPid Ltd.

PolyPid Ltd.

PYPDNASDAQHealthcare● Active
$4.62
+$0.12(+2.67%)
Market Cap$47081958
P/E Ratio—
52W High$5.21
52W Low$2.77
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

PolyPid Ltd. (PYPD) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PYPD · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.91pypd eps ttm · pypd earnings per shareEarnings history
PE Ratio (TTM)—pypd pe ratio ttm · pypd price to earningsPE Ratio deep dive
Revenue (TTM)0.00pypd revenue ttm · pypd annual revenueFull revenue history
Dividend YieldNo Dividenddoes pypd pay dividends · pypd dividend yieldDividend history
Shares Outstanding16.3Mpypd shares outstanding · pypd floatShares outstanding history
Next EarningsAug 12, 2026Est.pypd earnings date · pypd next earningsEarnings history

Explore PolyPid Ltd. Data

pypd stock data · financials
Market Cap$47.1Mpypd market cap · pypd valuation
Analyst Forecast$10 · Buy
DividendsNo Dividenddoes polypid ltd. pay dividends · pypd dividend yield
Revenue—polypid ltd. annual revenue · pypd revenue
EarningsEPS $-2.09+57.43%pypd earnings · pypd eps
PE Ratio—pypd pe ratio · pypd price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
polypid ltd. revenue · pypd revenue 2025
FY 2025Net Income-$34.2M▼ 17.73% YoY
202320242025
polypid ltd. net income · pypd profit 2025
FY 2025EPS$-2.09▲ +57.43% YoY
202320242025
pypd eps · polypid ltd. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$33.6MEPS: $-1.91View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy9 analystsis pypd a buy · pypd analyst rating
Strong Buy
0
Buy
8
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$9.00Low
$4.62Current
$9.50Avg Target105.63% upside
$10.00High
pypd price target · pypd 12 month forecast

Total: 9 · Buy rate: 88.9%

The PYPD analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $9.50, representing +105.63% upside from the current price of $4.62.

Stock Performance

Full History
1D+2.67%
1W-2.12%
1M+5.48%
3M+10.53%
YTD+6.45%
1Y+37.50%
5Y-98.30%

About PolyPid Ltd.

CEODikla Czaczkes Akselbrad
IPO DateJun 26, 2020
Employees57
CountryIL
Websitepolypid.com

PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary…

BiotechnologyHealthcareNASDAQIL

what is polypid ltd. · pypd stock overview · polypid ltd. company profile · who is polypid ltd. ceo · pypd NASDAQ · polypid ltd. headquarters · polypid ltd. business segments

About Stock Overview & Key Data

PolyPid Ltd. (PYPD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 26, 2020. As of the latest trading session, PYPD stock price is $4.62, with a market capitalization of $47.1M. The stock has returned +37.50% over the past 12 months and +6.45% year-to-date.

According to 9 Wall Street analysts, the consensus rating for PolyPid Ltd. stock is Buy, with an average 12-month price target of $9.50. In fiscal year 2025, PolyPid Ltd. reported revenue of — and net income of -$34.2M. For detailed data — including PolyPid Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, PolyPid Ltd. (PYPD) stock price is $4.62. The stock is traded on NASDAQ under the ticker symbol PYPD. The 52-week range is $2.77 – $5.21.

PYPD stock pricePYPD quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice